Remove BioTech Remove Mental health Remove Pharmaceuticals Remove Telehealth
article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

First, we look at the macro picture on health services utilization comparing the end of 2022 with pre-COVID-19 levels. we see an over-indexing of office, institutional and telehealth visits (at 108) and a 104 gauge on new prescriptions.

article thumbnail

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

Health Populi

Top-line, Accenture points to four pillars on which the pharma industry can “reinvent its relevance,” as the report title suggests: To express greater empathy, understanding the patient experience of delaying treatment, financial impacts, and mental health challenges the pandemic has caused.

article thumbnail

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

There is one health care public policy issue that unites U.S. Integrating with the telehealth service Care on the Optum Store. This last aspect is taking a strategic page out of the playbooks of Hims, Nurx, Ro, Truepill and other DTC-facing prescription drug + telehealth services that have proliferated in the U.S.